Solid cerebral microemboli and cerebrovascular symptoms in patients with prosthetic heart valves

Mona Skjelland1, Annika Michelsen, Frank Brosstad

  • 1Department of Neurology, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway. mona.skjelland@rikshospitalet.no

Stroke
|February 23, 2008
PubMed

Insights

Solid cerebral microemboli detected via transcranial Doppler ultrasonography in mechanical heart valve patients correlate with cerebrovascular symptoms. This finding may help predict ischemic stroke risk in this population.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Medical Imaging

Background:

  • Cerebral microemboli are frequently detected in patients with mechanical heart valves.
  • The clinical significance of these microemboli remains unclear.
  • Prosthetic heart valves, both mechanical and biologic, are used to treat valvular heart disease.

Purpose of the Study:

  • To determine the frequency and composition of cerebral microemboli in prosthetic heart valve patients.
  • To correlate microemboli findings with cerebrovascular symptoms.
  • To investigate the relationship between microemboli, inflammation, and coagulation parameters.

Main Methods:

  • Seventy-six patients with 81 prosthetic heart valves underwent multifrequency transcranial Doppler ultrasonography one year post-valve replacement.
  • Cerebrovascular events were recorded by a neurologist.
  • Inflammation and coagulation markers were measured using immunoassays.

Main Results:

  • Microemboli were exclusively detected in mechanical heart valve patients (56%).
  • Solid microemboli were identified in 34% of mechanical heart valve patients.
  • The presence of solid microemboli was significantly associated with cerebrovascular symptoms (P=0.026) and elevated monocyte chemotactic protein-1 levels (P=0.014).

Conclusions:

  • Solid cerebral microemboli are detectable in a significant portion of mechanical heart valve patients.
  • The detection of solid microemboli is linked to cerebrovascular events.
  • Detecting solid microemboli may aid in predicting ischemic stroke risk in mechanical heart valve recipients.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...